Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells

Pharmazie

Volumn 63, Issue 7, 2008, Pages 528-533

  Xu, Danqing ^a   Fang, Liang ^a   Zhu, Qionghua ^a   Hu, Yongzhou ^a   He, Qiaojun ^a   Yang, Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 BROMOPHENYL) 2,3 DIHYDRO N,3 BIS(3,4,5 TRIMETHOXYPHENYL) 2 OXOIMIDAZOLE 1 CARBOXAMIDE; COMBRETASTATIN A4; COMBRETASTATIN A4 DERIVATIVE; DAUNORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; MZ 3; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG RESEARCH; DRUG SPECIFICITY; DRUG SYNTHESIS; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LEUKEMIA; LEUKEMIA CELL; MDR1 GENE; MULTIDRUG RESISTANCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; G2 PHASE; HUMANS; IMIDAZOLES; LEUKEMIA; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 48249129967     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7854     Document Type: Article

References (16)

1. Cheng YF, Hu YZ, He QJ (2005) Synthesis and antitumor activity of arylsubstituted imidazolin-2-one derivatives. Yao Xue Xue Bao 40: 711-716.
2. Dowlati A, Robertson K, Cooney M, Petros WP, Stratford M, Jesberger J, Rafie N, Overmoyer B, Makkar V, Stambler B, Taylor A, Waas J, Lewin JS, McCrae KR, Remick SC (2002) A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. Cancer Res 62: 3408-3416.
3. Fang L, He Q, Hu Y, Yang B (2007) MZ3 induces apoptosis in human leukemia cells. Cancer Chemother Pharmacol 59: 397-405.
4. Gwaltney SL, Imade HM, Barr KJ, Li Q, Gehrke L, Credo RB, Warner RB, Lee JY, Kovar P, Wang J, Nukkala MA, Zielinski NA, Frost D, Ng SC, Sham HL (2001) Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents. Bioorg Med Chem Lett 11: 871-874.
5. Hao XS, Hao JH, Liu FT, Newland AC, Jia L (2003) Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis. Apoptosis. 8: 601-607.
6. Litman T, Zeuthen T, Skovsgaard T (1997) Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Biochim Biophys Acta 1361: 169-176.
7. Mahadevan D, List AF (2004) Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. Blood 104: 1940-1951.
8. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA (2007) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773: 1263-1284.
9. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM (2002) Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 51: 133-140.
10. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N (2002) Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel antiapoptotic factors IAP (inhibitory of apoptosis proteins). Cancer Lett 180: 91-101.
11. Notarbartolo M, Cervello M, Poma P, Dusonchet L, Meli M, D'Alessandro N (2004) Expression of the IAPs in multidrug resistant tumor cells. Oncol Rep 11: 133-136.
12. Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T; SHG AML96 Study Group (2005) MDR1 and MRP1 gene transcription are independent predictors for treatment outcome in adult acute myeloid leukaemia. Br J Haematol. 128: 324-332.
13. Steinbach D, Legrand O (2007) ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the hydra? Leukemia 21: 1172-1176.
14. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219-234.
15. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukaemias. Clin Cancer Res 6: 1796-1803.
16. Yang B, Reynolds CP (2005) Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Clin Cancer Res 11: 2774-2780.